Back
Cue Biopharma Vs. Arbutus Biopharma Industry Stock Comparison
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
Sell
41
ABUS
Arbutus Biopharma
Last Price:
3.63
Seasonality Move:
13.65%
Buy
54
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.50. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.63. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.50
The current trend is moderately bearish and CUE is experiencing slight selling pressure.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
CUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 50.94 | Buy |
Chaikin Money Flow: | -441294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.31 - 1.75) | Sell |
Bollinger Bands (100): | (0.58 - 1.36) | Buy |
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 35.92 | Sell |
Chaikin Money Flow: | -1077466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.76 - 4.08) | Sell |
Bollinger Bands (100): | (3.5 - 4.14) | Sell |
CUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.68 | Sell |
20-day SMA: | 1.62 | Sell |
50-day SMA: | 1.12 | Buy |
200-day SMA: | 1.41 | Buy |
8-day EMA: | 1.62 | Sell |
20-day EMA: | 1.54 | Sell |
50-day EMA: | 1.29 | Buy |
200-day EMA: | 1.47 | Buy |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.75 | Sell |
20-day SMA: | 3.9 | Sell |
50-day SMA: | 4.01 | Sell |
200-day SMA: | 3.34 | Buy |
8-day EMA: | 3.73 | Sell |
20-day EMA: | 3.84 | Sell |
50-day EMA: | 3.88 | Sell |
200-day EMA: | 3.42 | Buy |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Cue Biopharma Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arbutus Biopharma Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |